Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study.

Daniel RoesslerOsman ÖcalAlexander B PhilippDaniel MarkwardtStefan MunkerJulia MayerleLeonie S JochheimKatharina HammerChristian M LangeAndreas GeierMax SeidenstickerFlorian P ReiterEnrico N De ToniNajib Ben Khaled

Published in: Journal of cancer research and clinical oncology (2022)

This retrospective study demonstrates that combined ipilimumab and nivolumab can be effective and tolerable after prior ICI-based combination therapies and provides a rationale for the prospective clinical evaluation of this treatment sequencing.

Keyphrases

clinical trial
single cell
combination therapy
double blind
smoking cessation